Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1.
Weyland M, Manero F, Paillard A, Gr?e D, Viault G, Jarnet D, Menei P, Juin P, Chourpa I, Benoit JP, Gr?e R, Garcion E. Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. J Control Release. 2011 Apr 10; 151(1):74-82.